To further determine the potential role of PEA on the NLRP3 inflammasome pathway in MCD-treated NASH mice, we tested plasma IL-1β and IL-18 levels through ELISA assays. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatohepatitis.